Pulmonx (LUNG) Accumulated Depreciation & Amortization (2019 - 2025)

Pulmonx (LUNG) has 7 years of Accumulated Depreciation & Amortization data on file, last reported at $6.6 million in Q4 2025.

• Quarterly Accumulated Depreciation & Amortization rose 16.18% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.6 million (up 16.18% YoY) and the FY2025 annual result came in at $6.6 million, up 16.18% from the prior year.
• Accumulated Depreciation & Amortization improved to $6.6 million in Q4 2025 per LUNG's latest filing, from $6.6 million in the prior quarter.
• Across five years, Accumulated Depreciation & Amortization topped out at $6.6 million in Q4 2025 and bottomed at $1.9 million in Q1 2021.
• The 5-year median for Accumulated Depreciation & Amortization is $4.5 million (2023), against an average of $4.3 million.
• The widest annual swing landed in 2022, when Accumulated Depreciation & Amortization soared 58.54%; it then climbed 11.61% in 2025.
• Tracing LUNG's Accumulated Depreciation & Amortization over 5 years: stood at $2.2 million in 2021, then soared by 58.54% to $3.6 million in 2022, then jumped by 36.53% to $4.9 million in 2023, then increased by 17.9% to $5.7 million in 2024, then grew by 16.18% to $6.6 million in 2025.
• Per Business Quant, the three latest LUNG Accumulated Depreciation & Amortization figures stand at $6.6 million (Q4 2025), $6.6 million (Q3 2025), and $6.3 million (Q2 2025).

Peer Comparison